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A pragmatic, multi-centered,
stepped wedge, cluster randomized
controlled trial pilot of the clinical
and cost effectiveness of a complex
Stroke Oral healthCare intervention
pLan Evaluation II (SOCLE II)
compared with usual oral healthcare
in stroke wards
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Abstract
Background: Patients with stroke-associated pneumonia experience poorer outcomes (increased hospital stays, costs,
discharge dependency, and risk of death). High-quality, organized oral healthcare may reduce the incidence of stroke-
associated pneumonia and improve oral health and quality of life.
Aims: We piloted a pragmatic, stepped-wedge, cluster randomized controlled trial of clinical and cost effectiveness of
enhanced versus usual oral healthcare for people in stroke rehabilitation settings.
Methods: Scottish stroke rehabilitation wards were randomly allocated to stepped time-points for conversion from
usual to enhanced oral healthcare. All admissions and nursing staff were eligible for inclusion. We piloted the viability of
randomization, intervention, data collection, record linkage procedures, our sample size, screening, and recruitment
estimates. The stepped-wedge trial design prevented full blinding of outcome assessors and staff. Predetermined criteria
for progression included the validity of enhanced oral healthcare intervention (training, oral healthcare protocol,
assessment, equipment), data collection, and stroke-associated pneumonia event rate and relationship between
stroke-associated pneumonia and plaque.
Results: We screened 1548/2613 (59%) admissions to four wards, recruiting n¼ 325 patients and n¼ 112 nurses.
We observed marked between-site diversity in admissions, recruitment populations, stroke-associated pneumonia
events (0% to 21%), training, and resource use. No adverse events were reported. Oral healthcare documentation
was poor. We found no evidence of a difference in stroke-associated pneumonia between enhanced versus usual oral
healthcare (P¼ 0.62, odds ratio¼ 0.61, confidence interval: 0.08 to 4.42).
Conclusions: Our stepped-wedge cluster randomized control trial accommodated between-site diversity. The stroke-
associated pneumonia event rate did not meet our predetermined progression criteria. We did not meet our predefined
progression criteria including the SAP event rate and consequently were unable to establish whether there is a relation-
ship between SAP and plaque. A wide confidence interval did not exclude the possibility that enhanced oral healthcare
may result in a benefit or detrimental effect.
Trial Registration: NCT01954212.
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Introduction
Pneumonia is reported to impact 6% to 20% of stroke
survivors1,2 and is associated with poorer outcomes,
longer hospital stays, greater dependency at discharge,
greater healthcare costs, and risk of death.2–9 Stroke-
associated pneumonia (SAP) has been associated with
risk of aspiration4,10 as have stroke severity, alertness,
and functional ability,3 yet none fully explain the inci-
dence of SAP.3,5 The cleanliness of stroke survivors’
mouth and teeth may contribute to the development
of SAP.11,12
Stroke survivors have a higher prevalence of oral
Gram-negative bacteria than hospitalized nonstroke
peers.13 Aspiration of large numbers of such micro-
organisms may contribute to the incidence of
SAP.13–15 Dysphagia and poor oral clearance of food
and fluid residue further contribute to microbial load
and dental decay.13 Stroke admissions may have pre-
existing oral health problems, such as periodontitis,
which is linked to the incidence of cardiovascular dis-
ease, diabetes, and possibly stroke.13
Organized stroke care, such as protocols of care to
manage fever, glucose, and dysphagia,16 and specialist
stroke unit care17 benefit stroke survivors. High-quality
oral healthcare (OHC) may reduce the incidence of
SAP and improve patients’ oral health and quality of
life,11,18–21 but definitive randomized controlled trial
evidence in a stroke care setting is lacking.
Aim
Working with stroke survivors, carers, and a stroke
specialist multidisciplinary group, we co-produced a
clinically feasible enhanced OHC intervention.20 In
this study, we aimed to pilot the delivery of enhanced
OHC across multiple stroke wards in a pragmatic,
stepped-wedge, cluster randomized controlled trial of
the effectiveness of enhanced versus usual OHC.23
We considered whether our (i) randomization and
blinding procedures were robust; (ii) intervention,
data collection, and record linkage processes were
viable; (iii) sample size calculations and estimates of
screening, recruitment, consent, and retention required
refinement; (iv) participants adhered to the interven-
tion; (v) pneumonia event rates could be determined
across sites and over time; (vi) there was an association
between dental/denture plaque and SAP; and (vii)
planned statistical and health economic evaluations
were feasible. Our predetermined criteria for progres-
sion22 to a Phase III definitive RCT were as follows:
. Viability of the enhanced OHC intervention, data
collection processes, and protocol.
. Observation of at least 80% of the anticipated SAP
event rate among patient participants during usual
OHC. Where rates were 50% to 80%, we would
review our recruitment and SAP diagnostic criteria.
If less than 50%, we would reconsider our study
design.
. Establish that there is a relationship between SAP
and plaque.
Methods
Design
We collected usual OHC data (preintervention phase),
intervention data (conversion phase), and enhanced
OHC data (experimental phase) in a stepped wedge clus-
ter RCT (Supplementary Fig. 1). Using a computer-
based randomization sequence and concealment of allo-
cation, we randomly allocated stroke rehabilitation sites
to a sequence of fixed, stepped time-points to convert
from usual to enhanced OHC over 13 months at each
site (Supplementary Fig. 1). Additional trial design and
conduct details can be found in Supplementary File.
Participants
All admissions were eligible for inclusion in this prag-
matic trial, including all ages, dentition profiles, reason
for admission (including nonstroke), cognitive, and
communication impairment status. People with incap-
acity were eligible for inclusion. We sought welfare
guardians’ informed consent. Nursing staff (registered
nurses, nursing assistants, and student nurses) were eli-
gible for inclusion. We had no patient or staff exclusion
criteria. The Scotland A Research Ethics Committee
granted ethical approval (13/SS/1304).
Intervention
Our co-produced, multicomponent enhanced OHC
intervention sought improvements in stroke survivors’
OHC and outcomes as a consequence of staff delivering
enhanced OHC.20,23 Nurses were encouraged to partici-
pate in a 90-minute on-line OHC training course that
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provided evidence-based or best practice OHC infor-
mation and a tutorial on OHC assessment and care.22
Assessments and protocols were made available on the
ward.22 Staff had access to all necessary OHC equip-
ment, products, and specialist dental services.22
Interventions at patient level were not standardized in
this pragmatic trial but tailored by the nursing staff to
individuals’ needs by regimen, degree of support, equip-
ment, and products.
Data collection
Outcome data items were collected at patient, staff,
and service levels (Supplementary Table 1 including
refs.24–28).20 Caldicott Guardian approval granted
access to aggregated National Health Services UK data
on length of hospital stay and discharge for ward admis-
sions during the study period.We had no other follow-up.
Ward-level resource use data were also collected.
Statistical analysis
Analysis was on an intention-to-treat basis. Every effort
was made to retrieve missing data. Where outcome data
were missing, those records were removed from formal
statistical analysis relating to that outcome, unless
otherwise specified. The patient-level primary outcome
of SAP24 was summarized by study period and site.
Statistical analysis compared the incidence of pneumo-
nia between two time periods–before and during
enhanced OHC–using a logistic regression generalized
linear mixed model,29 which included site as a random
effect and date as a fixed effect. The intervention effect
was included as a fixed effect using an 0/1 indicator vari-
able to represent the periods before/during enhanced
OHC. We did not adjust for any other patient-level
covariates. Patient and staff recruitment rates were
estimated by the relevant proportion and its 95% confi-
dence interval (CI).
Results
Patients
We enrolled 325 patients of 1548 screened (proportion
21.0% (95% CI: 19.0%–23.1%)). We collected data
during usual OHC (135 patients; 105 after stroke),
intervention (n¼ 56; 38 stroke), and enhanced OHC
phases (n¼ 147; 99 stroke) (Supplementary Fig. 2;
Supplementary Table 2). Stroke Oral healthCare
pLan Evaluation (SOCLE) patients had a median age
of 76 (Inter-Quartile Range (IQR): 63 to 83) years and
their alertness, diagnosis, capacity to consent, modified
Rankin Scale (mRS), dentition, dysphagia, and nutri-
tional status were similar across sites 1 to 3
(Supplementary Tables 2 and 3). Few were considered
to lack mental capacity to make their own decisions
(n¼ 51; 15.7%). Site 4 differed with more female par-
ticipants, more alert, more disabled, incapacitated, with
dentures, and a nonstroke diagnosis. Stroke survivors
at site 4 (62% of site 4 participants) were a median of 8
(IQR: 0 to 22) days since stroke compared with sur-
vivors at sites 1 to 3 (76%–81% of site 1–3 participants)
who were admitted at stroke onset (median: 0; IQR: 0
to 1 days). No patients withdrew, dropped out, or
reported adverse events. The trial ended on schedule.
Twenty-five participants (7.4%) developed pneumo-
nia24 across the pilot with one site recording the
expected rates (n¼ 19; 21.1%). Physician diagnosis of
pneumonia was at a similar rate (8.3%). There was
considerable uncertainty regarding the association
between the pneumonia event rate and enhanced
OHC versus usual OHC (P¼ 0.62, OR: 0.61; CI: 0.08
to 4.42). Twelve participants contributed data to two
phases. One patient contributed across three phases
(both usual and enhanced care) but did not develop
pneumonia. Only the denominator in summaries and
modelling was affected, and thus, we made no adjust-
ment for repeated measures. Dental plaque, denture
plaque, and oral health-related quality-of-life scores
were similar between usual and enhanced OHC. No
adverse events were reported. Based on aggregated rou-
tinely collected data of 2613 ward admissions, 10
SOCLE participants died (of 238 across sites) in three
cases following pneumonia within 3 months of admis-
sion (Supplementary Table 4).
Nursing staff
We recruited 112 nursing staff of 123 employed (pro-
portion 91% (95% CI: 85% to 95%)) who contributed
data to the usual OHC (n¼ 108), intervention (n¼ 74),
and enhanced OHC phases (n¼ 83). They included
registered nurses (n¼ 62, 55%), assistants (n¼ 44,
39%), students (n¼ 5, 5%), and one was unreported.
Staff (n¼ 74) demonstrated no changes in their OHC
knowledge or OHC attitudes after training, nor did the
registered nurses differ from other nursing staff in their
scores (Supplementary Fig. 3). Documentation of OHC
assessment and care plans was poor but increased
slightly during the enhanced OHC phase (OHC find-
ings: usual care¼ 18/244 (7.4%), enhanced care¼ 32/
302 (10%), OHC plan usual care¼ 6/244 (2.5%) and
9/302 (3.0%)) particularly across sites 2–4).
In total, 37 registered general nurses (RGN) and 37
clinical support workers (CSW) completed the training
across the four sites. The assumed RGN salary was a
Band 6 (£44 per hour) and CSW salary was a Band 2
(£24 per hour).30 The median (1 h and 2min) and aver-
age time taken to complete (2 h and 17min) showed the
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range of training costs. Cost analysis indicated total
staff training costs of between a median of £446 to
£823 per site (£2600 across all sites) and mean of £986
to £1818 per site (£5745 across all sites).
Service level processes of care
Ten specialist dental referrals were made during the
trial and six during the usual OHC phase. Three sites
increased their monthly average delivery of denture
cups, saliva spray, toothpaste and Nystatin, and
mouthwash during enhanced OHC (Supplementary
Table 5). Resource use for equipment and products
was calculated for each site using reported information
and NHS procurement costs. During the usual care the
average monthly cost across four sites was £268 and,
during the enhanced OHC phase, the average monthly
cost was £248.
Discussion
We considered the strengths and limitations of this
study in the context of our predetermined principal
research questions and pilot trial progression criteria.22
Randomization and blinding procedures
Generation of our randomization sequence was
robust and our concealment of allocation process was
adhered to. We acknowledge the blinding limita-
tions in the context of a stepped-wedge cluster RCT
design. Future studies could ask researchers to indi-
cate which phase data collection contributed to as a
measure of blinding success. Training research staff to
collect data while withholding key information about
the trial design may be possible. We chose not to
do this.
Viability of intervention, data collection, and record
linkage processes
Our intervention was viable. Assessment, protocols,
and training were facilitated by senior nurses.
Through site engagement, we ensured availability of
dental equipment, products, and specialist services.
Data collection processes were feasible though record
linkage took considerable effort and required add-
itional permissions. Data collection during a full trial
may require modification given the increasing use of
electronic medical records though the recent general
data protection regulation31 may facilitate such investi-
gations in future. Shared responsibility across multiple
part-time recruiters, coupled with rapid discharge
resulted in many patients going unscreened and may
have had implications for patient recruitment.32
Estimates of screening, recruitment, consent and
retention, and adherence to the intervention
The routine health service data provided accurate
rates of patient flow through the ward, providing vital
insight to screening, recruitment, and consent rates.22
Few participants contributed data to more than one
phase and there was an absence of patient drop-out
from the trial. Few severely impaired, unconscious,
incapacitated participants participated in this trial.
Gatekeeper bias or recruitment logistics for this clinic-
ally relevant patient subgroup may have impacted on
recruitment profiles.33 Strategies to support the recruit-
ment of this clinically important subgroup to future
trials might include greater availability of
recruiters, alternatives to face-to-face information
provision and consenting, and better education of
research staff.
We observed poor staff adherence to the documen-
tation of OHC assessments and plans. A change from
paper to electronic records at two sites during the trial
(the OHC assessment record was reduced to a tick box
and there was no place to record an OHC plan) ham-
pered documentation. Adherence to the optional train-
ing component varied by site–between 80% and 94.7%
of staff at three sites participated in the training. In
contrast, less than half the staff (41.1%) in the fourth
site participated (Supplementary Fig. 2).
Pneumonia event rates and other between-site
diversity
Pneumonia event rates differed markedly across sites
with the overall event rate (7.4%) lower than previous
suggestions.2 Recent systematic review evidence sug-
gested an event rate of 6–10% is potentially a more
accurate multisite expectation.1,34 Site 4 dominated
the observed pneumonia rate, though there were
fewer deaths among these participants and thus may
suggest a selection effect, where very unwell patients
at emergency admission were not well enough to trans-
fer to that site. As a population however, the partici-
pants from the site were more severely affected by
stroke, incapacitated, and wore dentures than partici-
pants at other sites. The limited incidence of SAP
amongst study participants prevented further explor-
ation of the association with plaque (dental/denture).
We observed other marked differences between sites
including screening to recruitment conversion rates,
equipment use, and staff participation. More site 4
staff declined to participate in the study, but few
dropped out after recruitment. In contrast, many site
2 staff agreed to participate but exited the trial pretrain-
ing (n¼ 20) leaving just 38% to complete training
(13/34). Pre-existing access to specialist OHC products
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and dental health professionals varied by site; site 2
used fewer toothbrushes, denture cleaner, and tooth-
paste; and site 4 had voluntary input from specialist
dentist as required.
Modified sample size calculations for a
Phase III trial
We recruited fewer than estimated patient participants
(325–400 anticipated) and almost double the estimated
staff participants (112 compared with 60 anticipated).
The low pneumonia rate meant that we did not reach
our predetermined rate of 80% of the anticipated event
rate (20%). We reviewed the adjustment of the pneu-
monia diagnostic criteria but observed little difference
on the event rate (7.4% on primary outcome criteria;
8.3% through physician diagnosis). Through routine
data linkage, we know that 58 nonparticipants died fol-
lowing pneumonia. The high intracluster correlation
(Supplementary Fig. 3; ICC¼ 0.41) provides useful
information for planning future studies. Due to the
low incidence of pneumonia among SOCLE patients,
calculation of the ICC CI was impeded by the
sparse pneumonia counts across sites (Supplementary
Table 4).
Our SOCLE pilot is the largest multicentered trial of
an OHC intervention delivered to patients and staff in
typical stroke rehabilitation wards to date comparing
enhanced OHC provided by nurses to usual OHC and
its impact on SAP. The wide CI did not exclude the
possibility that enhanced OHC may result in a large
benefit or detrimental effect. Our pilot pragmatic trial
lacked power to draw firm conclusions about our pneu-
monia outcome (this was not our primary objective).
The clinical implications are few, though the range of
pneumonia event rates across sites is noteworthy and
may highlight the nature of clinical diversity across
wards perhaps because of different patient populations
at different sites.
Conclusion
Our SOCLE pilot trial findings showed that a large-
scale stepped-wedge cluster trial to evaluate the efficacy
and effectiveness of a complex OHC intervention versus
standard NHS care for oral health after stroke
was feasible and accommodated marked between-site
diversity. Electronic records should support documen-
tation of OHC assessments and plans. We did not meet
our predefined progression criteria including the SAP
event rate and consequently were unable to establish
whether there is a relationship between SAP and
plaque. Future trials should base SAP expectations on
recent multisite incidence data and consensus defin-
itions of SAP.
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